Health Invest Partners Ab has filed its 13F form on April 25, 2024 for Q1 2024 where it was disclosed a total value porftolio of $161 Million distributed in 44 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merck & Co., Inc. with a value of $17.6M, Eli Lilly & CO with a value of $16.2M, Unitedhealth Group Inc with a value of $11.4M, Thermo Fisher Scientific Inc. with a value of $8.83M, and Neurocrine Biosciences Inc with a value of $6M.
Examining the 13F form we can see an increase of $35M in the current position value, from $126M to 161M.
Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.